Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study
This retrospective study aimed to assess the safety of patients with severe cerebral palsy (CP), who received allogeneic umbilical cord blood stem cells (UCBSCs) treatment from August 2009 to December 2012 in Guangdong Provincial Hospital of Chinese Medicine. A total of 47 patients with average age...
Main Authors: | Mei Feng, Aili Lu, Hongxia Gao, Caiwen Qian, Jun Zhang, Tongxiang Lin, Yuanqi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2015/325652 |
Similar Items
-
Umbilical Cord Blood and Umbilical Cord Tissue Mesenchymal Stromal Cells in Children with Cerebral Palsy: A Randomized Trial
by: Jessica Sun, et al.
Published: (2021-09-01) -
Sibling umbilical cord blood infusion is safe in young children with cerebral palsy
by: Jessica M. Sun, et al.
Published: (2021-09-01) -
Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions
by: Luo Xiao-Ling, et al.
Published: (2010-08-01) -
Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial
by: Jiaowei Gu, et al.
Published: (2020-02-01) -
Therapy for Cerebral Palsy by Human Umbilical Cord Blood Mesenchymal Stem Cells Transplantation Combined With Basic Rehabilitation Treatment
by: Che Zhang MD, et al.
Published: (2015-03-01)